PEPINEMAB
UNII BPZ4A29SYE

Substance Identification & Data

This profile provides standardized clinical and technical data for Pepinemab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BPZ4A29SYE.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2097151-87-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

BPZ4A29SYE

CAS Registry Number

2097151-87-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PEPINEMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C96222

National Cancer Institute reference terminology for clinical and research data.

INN ID

11011

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

FG-76

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pepinemab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PEPINEMAB

Common Names & Synonyms

ANTI-SEMA4D MONOCLONAL ANTIBODY VX15/2503

PEPINEMAB [INN]

PEPINEMAB [USAN]

PEPINEMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4 (226-PROLINE), ANTI-(HUMAN SEMAPHORIN 4D)(HUMANIZED MONOCLONAL VX-15/2503 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL VX-15/2503 .KAPPA.-CHAIN, DIMER

SYS

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS SEMA4D (SEMAPHORIN 4D, CD100)), MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN (1-445) (VH (HOMO SAPIENS IGHV1-46*01 (82.7%)-(IGHD)-IGHJ3*01 (92.9%)) (8.8.11) (1-118)-HOMO SAPIENS IGHG4*01 (CH1 (119-216), HINGE S10>P (226)(217-228), CH2 (229-338), CH3 (339-443), CHS (444-445)) (119-445)), (132-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') (V-KAPPA (MUS MUSCULUS IGKV3-4*01 (85.9%)-(IGHD)-IGKJ2*03 (91.7%)/HOMO SAPIENS IGKV4-1*01 (83.2%)-IGKJ2*01 (100%)) (10.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218'))DIMER (224-224'':227-227'')-BISDISULFIDE

SYS

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS SEMAPHORINE-D4 (CD100 ANTIGEN))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.4 HEAVY CHAIN (1-445) (HUMANIZED VH (HOMO SAPIENS IGHV1-46*01 (83%) (IGHD)-IGHJ3*01 (93%)) (8.8.11) (1-118)-HOMO SAPIENS IGHG4*01 (HINGE(S10>P(226))) (119-445)) (132-218')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-218') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV4-1*01 (83%) IGKJ2*01)(12.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (112'-218'))DIMER (224-224'':227-227'')-BISDISULFIDE

SYS